Annual Short Term Debt
$5.89 M
+$143.00 K+2.49%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual short term debt is $5.89 million, with the most recent change of +$143.00 thousand (+2.49%) on December 31, 2021.
- During the last 3 years, PHAS annual short term debt has risen by +$5.89 million (+100.00%).
Performance
PHAS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$4.50 M
-$1.37 M-23.35%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly short term debt is $4.50 million, with the most recent change of -$1.37 million (-23.35%) on June 30, 2022.
- Over the past year, PHAS quarterly short term debt has dropped by -$1.36 million (-23.16%).
Performance
PHAS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
PHAS Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.5% | -23.2% |
| 3 y3 years | +100.0% | +194.1% |
| 5 y5 years | -54.2% | - |
PHAS Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -23.5% | at low |
| 5 y | 5-year | at high | -55.1% | -23.5% | -41.3% |
| alltime | all time | -54.2% | -100.0% | -65.0% | -100.0% |
PhaseBio Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $4.50 M(-23.4%) |
| Mar 2022 | - | $5.88 M(-0.2%) |
| Dec 2021 | $5.89 M(+2.5%) | $5.89 M(+0.1%) |
| Sep 2021 | - | $5.88 M(+0.4%) |
| Jun 2021 | - | $5.86 M(+0.4%) |
| Mar 2021 | - | $5.84 M(+1.6%) |
| Dec 2020 | $5.75 M | $5.75 M(-0.8%) |
| Sep 2020 | - | $5.79 M(+6.5%) |
| Jun 2020 | - | $5.44 M(+37.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.96 M(+49.7%) |
| Dec 2019 | $2.64 M(>+9900.0%) | $2.64 M(+18.6%) |
| Sep 2019 | - | $2.23 M(+45.6%) |
| Jun 2019 | - | $1.53 M(+123.5%) |
| Mar 2019 | - | $685.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $3.13 M(-7.0%) |
| Jun 2018 | - | $3.36 M(-73.9%) |
| Dec 2017 | $12.86 M | $12.86 M |
FAQ
- What is PhaseBio Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual short term debt year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly short term debt year-on-year change?
What is PhaseBio Pharmaceuticals annual short term debt?
The current annual short term debt of PHAS is $5.89 M
What is the all time high annual short term debt for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual short term debt is $12.86 M
What is PhaseBio Pharmaceuticals annual short term debt year-on-year change?
Over the past year, PHAS annual short term debt has changed by +$143.00 K (+2.49%)
What is PhaseBio Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of PHAS is $4.50 M
What is the all time high quarterly short term debt for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly short term debt is $12.86 M
What is PhaseBio Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, PHAS quarterly short term debt has changed by -$1.36 M (-23.16%)